These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1442827)

  • 1. FDA requires further trials for antiendotoxin monoclonal antibody products.
    Am J Hosp Pharm; 1992 Aug; 49(8):1848, 1850. PubMed ID: 1442827
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory agency concerns in the manufacturing and testing of monoclonal antibodies for therapeutic use.
    Baker DA; Harkonen WS
    Targeted Diagn Ther; 1990; 3():75-98. PubMed ID: 2131019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industry looks to buck bias in emerging 'adaptive' designs.
    Torres C
    Nat Med; 2010 Jun; 16(6):619. PubMed ID: 20526301
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA approves new kind of lymphoma treatment. Food and Drug Administration.
    James JS; Dubs G
    AIDS Treat News; 1997 Dec; (No 284):2-3. PubMed ID: 11364912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA publishes conflict of interest rules for clinical trials. Food and Drug Administration.
    James JS
    AIDS Treat News; 1998 Mar; (No 290):8. PubMed ID: 11365123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New clinical trials policy at FDA.
    Vastag B
    Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA tells senators of doctors who fake data in clinical drug trials.
    Holden C
    Science; 1979 Oct; 206(4417):423-3. PubMed ID: 504984
    [No Abstract]   [Full Text] [Related]  

  • 9. Fast track to MS drug.
    Sheridan C
    Nat Biotechnol; 2004 Aug; 22(8):939-41. PubMed ID: 15286635
    [No Abstract]   [Full Text] [Related]  

  • 10. Tricky FDA debate: should a risky drug be approved again?
    Mathews AW; Westphal SP
    Wall St J (East Ed); 2006 Feb; ():B1, B4. PubMed ID: 16528879
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM
    Curr Opin Mol Ther; 2002 Apr; 4(2):110-8. PubMed ID: 12044031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoma treatment approved.
    AIDS Patient Care STDS; 1998 Mar; 12(3):231. PubMed ID: 11361944
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric drug development in anesthesiology: an FDA perspective.
    Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
    Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
    [No Abstract]   [Full Text] [Related]  

  • 14. How FDA approves biotechnology drugs.
    Manuel SM; Piascik P
    Am Pharm; 1995 May; NS35(5):14-5. PubMed ID: 7611131
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 16. IL-1 trap go-ahead.
    Ratner M
    Nat Biotechnol; 2008 May; 26(5):485. PubMed ID: 18464767
    [No Abstract]   [Full Text] [Related]  

  • 17. Findings halt clinical trials of centoxin.
    Wagner M
    Mod Healthc; 1993 Jan; 23(4):16. PubMed ID: 10123669
    [No Abstract]   [Full Text] [Related]  

  • 18. Off-label uses of monoclonal antibodies for treatment of B-cell lymphoid or myeloid malignancies.
    Tecnologica MAP Suppl; 2001 Jul; ():14-7. PubMed ID: 11718149
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted therapy trials: approval strategies, target validation, or helping patients?
    Hoff PM; Ellis LM
    J Clin Oncol; 2007 May; 25(13):1639-41. PubMed ID: 17470854
    [No Abstract]   [Full Text] [Related]  

  • 20. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.